272 related articles for article (PubMed ID: 2441891)
1. Analysis of the properties of binding of calcium-channel activators and inhibitors to dihydropyridine receptors in chick heart membranes.
Maan AC; Hosey MM
Circ Res; 1987 Sep; 61(3):379-88. PubMed ID: 2441891
[TBL] [Abstract][Full Text] [Related]
2. Thermodynamic and kinetic aspects of agonist and antagonist binding to 1,4-dihydropyridine receptors.
Zheng W; Hawthorn M; Triggle DJ
Eur J Pharmacol; 1991 Oct; 208(2):137-47. PubMed ID: 1724760
[TBL] [Abstract][Full Text] [Related]
3. Influence of Mg++ on the effect of diltiazem to increase dihydropyridine binding to receptors on Ca++-channels in chick cardiac and skeletal muscle membranes.
Maan AC; Ptasienski J; Hosey MM
J Pharmacol Exp Ther; 1986 Dec; 239(3):768-74. PubMed ID: 2432217
[TBL] [Abstract][Full Text] [Related]
4. A comparison between the binding and electrophysiological effects of dihydropyridines on cardiac membranes.
Hamilton SL; Yatani A; Brush K; Schwartz A; Brown AM
Mol Pharmacol; 1987 Mar; 31(3):221-31. PubMed ID: 2436031
[TBL] [Abstract][Full Text] [Related]
5. Competitive binding experiments reveal differential interactions for dihydropyridine calcium channel activators and antagonists at dihydropyridine receptors on mouse brain membranes.
O'Neill SK; Triggle CR; Bolger GT
Can J Physiol Pharmacol; 1994 Jul; 72(7):738-45. PubMed ID: 7530159
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the calcium channel activating 3H-BAY K 8644 and inhibiting 3H-verapamil with specific receptor sites on cultured beating myocardial cells.
Bellemann P
J Recept Res; 1984; 4(1-6):571-85. PubMed ID: 6084713
[TBL] [Abstract][Full Text] [Related]
7. [3H]BAY K 8644, a 1,4-dihydropyridine Ca++ channel activator: characteristics of binding to high and low affinity sites in cardiac membranes.
Sarmiento JG; Shrikhande AV; Janis RA; Triggle DJ
J Pharmacol Exp Ther; 1987 Apr; 241(1):140-6. PubMed ID: 2437286
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel calcium antagonist binding site in rat brain by SR 33557.
Kenny BA; Fraser S; Spedding M
Br J Pharmacol; 1993 Jan; 108(1):93-9. PubMed ID: 7679034
[TBL] [Abstract][Full Text] [Related]
9. Molecular approach to the calcium channel.
Glossmann H; Ferry DR; Goll A; Linn T
Adv Myocardiol; 1985; 5():41-76. PubMed ID: 2578683
[TBL] [Abstract][Full Text] [Related]
10. Comparative aspects and temperature dependence of [3H]1,4-dihydropyridine Ca2+ channel antagonist and activator binding to neuronal and muscle membranes.
Rampe D; Luchowski E; Rutledge A; Janis RA; Triggle DJ
Can J Physiol Pharmacol; 1987 Jul; 65(7):1452-60. PubMed ID: 2444320
[TBL] [Abstract][Full Text] [Related]
11. Binding of Ca2+ entry blockers to cardiac sarcolemmal membrane vesicles. Characterization of diltiazem-binding sites and their interaction with dihydropyridine and aralkylamine receptors.
Garcia ML; King VF; Siegl PK; Reuben JP; Kaczorowski GJ
J Biol Chem; 1986 Jun; 261(18):8146-57. PubMed ID: 2424894
[TBL] [Abstract][Full Text] [Related]
12. The effects of strychnine on the regulation of voltage-dependent calcium channels by dihydropyridines in brain and heart.
O'Neill SK; Bolger GT
Pharmacol Biochem Behav; 1990 Apr; 35(4):833-40. PubMed ID: 1693213
[TBL] [Abstract][Full Text] [Related]
13. Specific binding of a calcium channel activator, [3H]BAY k 8644, to membranes from cardiac muscle and brain.
Janis RA; Rampe D; Sarmiento JG; Triggle DJ
Biochem Biophys Res Commun; 1984 May; 121(1):317-23. PubMed ID: 6203531
[TBL] [Abstract][Full Text] [Related]
14. High affinity specific [3H](+)PN 200-110 binding to dihydropyridine receptors associated with calcium channels in rat cerebral cortex and heart.
Lee HR; Roeske WR; Yamamura HI
Life Sci; 1984 Aug; 35(7):721-32. PubMed ID: 6088927
[TBL] [Abstract][Full Text] [Related]
15. Purified calcium channels have three allosterically coupled drug receptors.
Striessnig J; Goll A; Moosburger K; Glossmann H
FEBS Lett; 1986 Mar; 197(1-2):204-10. PubMed ID: 2419161
[TBL] [Abstract][Full Text] [Related]
16. Dihydropyridine-sensitive Ca2+ channels: molecular properties of interaction with Ca2+ channel blockers, purification, subunit structure, and differentiation.
Lazdunski M; Barhanin J; Borsotto M; Fosset M; Galizzi JP; Renaud JF; Romey G; Schmid A
J Cardiovasc Pharmacol; 1986; 8 Suppl 8():S13-9. PubMed ID: 2433514
[TBL] [Abstract][Full Text] [Related]
17. Photoaffinity labeling with dihydropyridine derivatives of crude membranes from rat skeletal, cardiac, ileal, and uterine muscles and whole brain.
Ichida S; Masada A; Fujisue T; Yoshioka T; Matsuda N
J Biochem; 1989 May; 105(5):767-74. PubMed ID: 2473981
[TBL] [Abstract][Full Text] [Related]
18. Photoaffinity labelling of the cardiac calcium channel. (-)-[3H]azidopine labels a 165 kDa polypeptide, and evidence against a [3H]-1,4-dihydropyridine-isothiocyanate being a calcium-channel-specific affinity ligand.
Ferry DR; Goll A; Glossmann H
Biochem J; 1987 Apr; 243(1):127-35. PubMed ID: 2440422
[TBL] [Abstract][Full Text] [Related]
19. High and low affinity states of the dihydropyridine and phenylalkylamine receptors on the cardiac calcium channel and their interconversion by divalent cations.
Ptasienski J; McMahon KK; Hosey MM
Biochem Biophys Res Commun; 1985 Jun; 129(3):910-7. PubMed ID: 2409972
[TBL] [Abstract][Full Text] [Related]
20. Voltage-dependent binding of 1,4-dihydropyridine Ca2+ channel antagonists and activators in cultured neonatal rat ventricular myocytes.
Wei XY; Rutledge A; Triggle DJ
Mol Pharmacol; 1989 Apr; 35(4):541-52. PubMed ID: 2539561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]